# Dexlansoprazole Absorption and Marginal Ulceration After Gastric Bypass

> **NCT04423588** · PHASE4 · WITHDRAWN · sponsor: **Spital Limmattal Schlieren**

## Conditions studied

- Bariatric Surgery

## Interventions

- **DIAGNOSTIC_TEST:** dexlansoprazole serum concentration
- **DIAGNOSTIC_TEST:** upper endoscopy

## Key facts

- **NCT ID:** NCT04423588
- **Lead sponsor:** Spital Limmattal Schlieren
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01-01
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-09-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants enrolled.
- **Last updated:** 2024-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04423588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04423588, "Dexlansoprazole Absorption and Marginal Ulceration After Gastric Bypass". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04423588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*